Ingrid C. McCall

Ingrid C. McCall

Auto-generated profile, based on publicly available information

Ingrid C. McCall

Department of Biology, Emory University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
BBBrandon A Berryhill
Brandon A Berryhill
DHDouglas L. Huseby
Douglas L. Huseby
IMIngrid C. McCall
Ingrid C. McCall
DHDiarmaid Hughes
Diarmaid Hughes
BLBruce Levin
Bruce Levin
Significance: This study explores the potential of a phage, PYO Sa , for treating Staphylococcus aureus infections in combination with antibiotics. Population dynamic and genomic analysis identified a limitation and potential liability of using PYO Sa for therapy. Due to the production of potentially pathogenic atypical small colony variants, PYO Sa alone cannot eliminate S. aureus populations. However, we demonstrate that by following the administration of PYO Sa with bactericidal antibiotics, this limitation and potential liability can be addressed. The methods used in this investigation to explore the efficacy of combinations of PYO Sa and antibiotics for treating S. aureus  infections can be employed to evaluate the clinical potential and facilitate the design of treatment protocols for any bacteria and phage that can be cultured in vitro.

1 December 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
WLWinston Y. Lee
Winston Y. Lee
DWDominique A. Weber
Dominique A. Weber
OLOskar Laur
Oskar Laur
SSSean R. Stowell
Sean R. Stowell
IMIngrid McCall
Ingrid McCall
CPCharles A. Parkos
Charles A. Parkos
Interaction of SIRPα with its ligand, CD47, regulates leukocyte functions, including transmigration, phagocytosis, oxidative burst, and cytokine secretion. Recent progress has provided significant insights into the structural details of the distal IgV domain (D1) of SIRPα. However, the structural roles of proximal IgC domains (D2 and D3) have been largely unstudied. The high degree of conservation of D2 and D3 among members of the SIRP family as well as the propensity of known IgC domains to assemble in cis has led others to hypothesize that SIRPα forms higher order structures on the cell surface. Here we report that SIRPα forms noncovalently linked cis homodimers. Treatment of SIRPα-expressing cells with a membrane-impermeable cross-linker resulted in the formation of SDS-stable SIRPα dimers and oligomers. Biochemical analyses of soluble recombinant extracellular regions of SIRPα, including domain truncation mutants, revealed that each of the three extracellular immunoglobulin loops of SIRPα formed dimers in solution. Co-immunoprecipitation experiments using cells transfected with different affinity-tagged SIRPα molecules revealed that SIRPα forms cis dimers. Interestingly, in cells treated with tunicamycin, SIRPα dimerization but not CD47 binding was inhibited, suggesting that a SIRPα dimer is probably bivalent. Last, we demonstrate robust dimerization of SIRPa in adherent, stimulated human neutrophils. Collectively, these data are consistent with SIRPα being expressed on the cell surface as a functional cis-linked dimer.

11 May 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
BBBrandon A Berryhill
Brandon A Berryhill
RGRodrigo García
Rodrigo García
IMIngrid C. McCall
Ingrid C. McCall
WCWaqas Chaudhry
Waqas Chaudhry
MPMarie-Agnès Petit
Marie-Agnès Petit
BLBruce Levin
Bruce Levin
The most significant difference between bacteriophages functionally and ecologically is whether they are purely lytic (virulent) or temperate. Virulent phages can only be transmitted horizontally by infection, most commonly with the death of their hosts. Temperate phages can also be transmitted horizontally, but upon infection of susceptible bacteria, their genomes can be incorporated into that of their host’s as a prophage and be transmitted vertically in the course of cell division by their lysogenic hosts. From what we know from studies with the temperate phage Lambda and other temperate phages, in laboratory culture, lysogenic bacteria are protected from killing by the phage coded for by their prophage by immunity; where upon infecting lysogens, the free temperate phage coded by their prophage are lost. Why are lysogens not also resistant as well as immune to the phage coded by their prophage since immunity does not confer protection against virulent phages? To address this question, we used a mathematical model and performed experiments with temperate and virulent mutants of the phage Lambda in laboratory culture. Our models predict and experiments confirm that selection would favor the evolution of resistant as well as immune lysogens, particularly if the environment includes virulent phage that share the same receptors as the temperate. To explore the validity and generality of this prediction, we examined ten lysogenic Escherichia coli from natural populations. All ten were capable of forming immune lysogens but their original hosts were resistant to the phage coded by their prophage. Significance Statement: This jointly theoretical and experimental study predicted that lysogenic bacteria, will be resistant as well as immune to the phage coded for by their prophage. All ten naturally occurring lysogenic Escherichia coli tested were resistant to the temperate phage coded for by their prophage.